Intravitreal infliximab for refractory pseudophakic cystoid macular edema: Results of the Pan-American Collaborative Retina Study Group

International Ophthalmology

Volumn 32, Issue 3, 2012, Pages 235-243

  Wu, Lihteh ^a   Fernando Arevalo, J ^b   Hernandez Bogantes, Erick ^a   Roca, José A ^c  

^a Instituto de Cirugia Ocular   (Costa Rica)

^b Centro Caracas   (Venezuela)

^c CLÍNICA RICARDO PALMA   (Peru)

Author keywords

Cataract surgery; Cystoid macular edema; Infliximab; Intravitreal injection; Tumor necrosis factor

Indexed keywords

INFLIXIMAB; STEROID;

ADULT; AGED; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; HUMAN; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; IRIDOCYCLITIS; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; REFRACTORY PSEUDOPHAKIC CYSTOID MACULAR EDEMA; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; SYSTEMIC DISEASE; VISUAL ACUITY; VITREOUS HEMORRHAGE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CATARACT EXTRACTION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; OFF-LABEL USE; PSEUDOPHAKIA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TUMOR NECROSIS FACTOR-ALPHA; VISUAL ACUITY; YOUNG ADULT;

EID: 84864290002     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-012-9559-8     Document Type: Article

References (28)

1. Flach AJ (1998) The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96:557-634 (Pubitemid 29012928)
2. Gallego-Pinazo R, Arevalo JF, Udaondo P, Garcia-Delpech S, Dolz-Marco R, Diaz-Llopis M (2011) Prophylaxis of pseudophakic cystoid macular edema with intraoperative pegaptanib. J Ocul Pharmacol Ther 28:65-68
3. Levin DS, Lim JI (2002) Update on pseudophakic cystoid macular edema treatment options. Ophthalmol Clin North Am 15:467-472 (Pubitemid 36076602)
4. StarkWJ Jr, Maumenee AE, Fagadau W, DatilesM, Baker CC, Worthen D, Klein P, Auer C (1984) Cystoidmacular edema in pseudophakia. Surv Ophthalmol 28(Suppl):442-451
5. Miyake K, Ibaraki N (2002) Prostaglandins and cystoid macular edema. Surv Ophthalmol 47(Suppl 1):S203-S218 (Pubitemid 35232234)
6. Rabinovich CE (2007) Use of tumor necrosis factor inhibitors in uveitis. Curr Opin Rheumatol 19:482-486 (Pubitemid 47344242)
7. Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, Gomez Vidal MA, Collantes Estevez E, Ramirez Chamond R, Omar M (2001) Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 33:251-255 (Pubitemid 34701624)
8. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE (2004) Macular edema. Surv Ophthalmol 49:470-490 (Pubitemid 39504763)
9. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA (2003) Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 29:27-33 (Pubitemid 36152276)
10. Rho DS (2003) Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg 29:2378-2384 (Pubitemid 38049737)
11. Steinert RF, Wasson PJ (1989) Neodymium:YAG laser anterior vitreolysis for Irvine-Gass cystoid macular edema. J Cataract Refract Surg 15:304-307 (Pubitemid 19142822)
12. Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW Jr (1995) Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 120:302-307
13. Arevalo JF, Garcia-Amaris RA, Roca JA, Sanchez JG, Wu L, Berrocal MH, Maia M (2007) Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg 33:2098-2105 (Pubitemid 350167520)
14. Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L (2009) Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan- American Collaborative Retina Study Group results. Ophthalmology 116:1481-1487, 1487 e1481
15. Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP (2004) Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol 138:648-650 (Pubitemid 39420497)
16. Suhler EB, Smith JR, Giles TR, Lauer AK, Wertheim MS, Kurz DE, Kurz PA, Lim L, Mackensen F, Pickard TD, Rosenbaum JT (2009) Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol 127:819-822
17. Suhler EB, Smith JR, Wertheim MS, Lauer AK, Kurz DE, Pickard TD, Rosenbaum JT (2005) A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 123:903-912 (Pubitemid 41057986)
18. Kruglov AA, Kuchmiy A, Grivennikov SI, Tumanov AV, Kuprash DV, Nedospasov SA (2008) Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models. Cytokine Growth Factor Rev 19:231-244
19. Giansanti F, Ramazzotti M, Vannozzi L, Rapizzi E, Fiore T, Iaccheri B, Degl' Innocenti D, Moncini D, Menchini U (2008) A pilot study on ocular safety of intravitreal infliximab in a rabbit model. Invest Ophthalmol Vis Sci 49:1151-1156
20. Theodossiadis PG, Liarakos VS, Sfikakis PP, Charonis A, Agrogiannis G, Kavantzas N, Vergados IA (2009) Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit. Graefes Arch Clin Exp Ophthalmol 247:273-281
21. Theodossiadis PG, Liarakos VS, Sfikakis PP, Vergados IA, Theodossiadis GP (2009) Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am J Ophthalmol 147:825-830, 830 e821
22. Giganti M, Beer PM, Lemanski N, Hartman C, Schartman J, Falk N (2010) Adverse events after intravitreal infliximab (Remicade). Retina 30:71-80
23. Kent D, Vinores SA, Campochiaro PA (2000) Macular oedema: the role of soluble mediators. Br J Ophthalmol 84:542-545 (Pubitemid 30251721)
24. Farvardin M, Afarid M, Mehryar M, Hosseini H (2010) Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis. Retina 30:1530-1535
25. Arias L, Caminal JM, Badia MB, Rubio MJ, Catala J, Pujol O (2010) Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy. Retina 30:1601-1608
26. Wu L, Hernandez-Bogantes E, Roca JA, Arevalo JF, Barraza K, Lasave AF (2011) Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group. Retina 31:298-303
27. Androudi S, Tsironi E, Kalogeropoulos C, Theodoridou A, Brazitikos P (2010) Intravitreal adalimumab for refractory uveitis-related macular edema. Ophthalmology 117:1612-1616
28. Tsilimbaris M, Diakonis VF, Naoumidi I, Charisis S, Kritikos I, Chatzithanasis G, Papadaki T, Plainis S (2009) Evaluation of potential retinal toxicity of adalimumab (Humira). Graefes Arch Clin Exp Ophthalmol 247:1119-1125